Q4 2023 Holdings
Filed 2024-02-14 | 69 holdings | $734.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK)Call | COM NEW | 23282W605 | $33.4M | 400,000 | 4.5% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $28.7M | 1,100,000 | 3.9% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $26.4M | 350,000 | 3.6% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $26.3M | 170,000 | 3.6% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $22.7M | 225,000 | 3.1% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $22.0M | 25,000 | 3.0% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $21.7M | 375,000 | 3.0% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $19.9M | 400,000 | 2.7% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $17.5M | 70,000 | 2.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $16.7M | 200,000 | 2.3% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $16.7M | 250,000 | 2.3% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $16.3M | 28,000 | 2.2% |
| Dexcom Inc(DXCM) | COM | 252131107 | $15.5M | 125,000 | 2.1% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $15.4M | 65,000 | 2.1% |
| Cencora Inc(COR) | COM | 03073E105 | $14.4M | 70,000 | 2.0% |
| Natera Inc(NTRA) | COM | 632307104 | $14.1M | 225,000 | 1.9% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $13.5M | 40,000 | 1.8% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $13.3M | 220,000 | 1.8% |
| Cooper COS Inc | COM NEW | 216648402 | $13.2M | 35,000 | 1.8% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $12.9M | 140,000 | 1.8% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $12.5M | 175,000 | 1.7% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $12.2M | 60,000 | 1.7% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $12.2M | 100,000 | 1.7% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $11.9M | 90,000 | 1.6% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $11.8M | 520,000 | 1.6% |
| Laboratory Corp Amer Hldgs | COM NEW | 50540R409 | $11.4M | 50,000 | 1.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $10.8M | 350,000 | 1.5% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $10.7M | 70,000 | 1.5% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $10.5M | 85,000 | 1.4% |
| Penumbra Inc(PEN) | COM | 70975L107 | $10.1M | 40,000 | 1.4% |
| Icon PLC(ICLR) | SHS | G4705A100 | $9.9M | 35,000 | 1.3% |
| Repligen Corp(RGEN) | COM | 759916109 | $9.9M | 55,000 | 1.3% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $9.9M | 120,000 | 1.3% |
| Centene Corp del(CNC) | COM | 15135B101 | $9.6M | 130,000 | 1.3% |
| Elevance Health Inc(ELV) | COM | 036752103 | $9.4M | 20,000 | 1.3% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $9.3M | 500,000 | 1.3% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $8.9M | 160,000 | 1.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $8.6M | 45,000 | 1.2% |
| Cytokinetics Inc(CYTK)Put | COM NEW | 23282W605 | $8.3M | 100,000 | 1.1% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $8.3M | 250,000 | 1.1% |
| Align Technology Inc(ALGN) | COM | 016255101 | $8.2M | 30,000 | 1.1% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $7.6M | 375,000 | 1.0% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $7.5M | 500,000 | 1.0% |
| Bruker Corp(BRKR) | COM | 116794108 | $7.3M | 100,000 | 1.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $7.2M | 175,000 | 1.0% |
| Hologic Inc(HOLX) | COM | 436440101 | $7.1M | 100,000 | 1.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $7.1M | 200,000 | 1.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $7.0M | 50,000 | 0.9% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $6.9M | 249,000 | 0.9% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $6.6M | 315,000 | 0.9% |